MATERNAL PLASMA TRANSCRIPTOME ANALYSIS BY MASSIVELY PARALLEL RNA SEQUENCING
    1.
    发明申请
    MATERNAL PLASMA TRANSCRIPTOME ANALYSIS BY MASSIVELY PARALLEL RNA SEQUENCING 审中-公开
    通过大规模并行RNA序列的MATERNAL PLASMA转录分析

    公开(公告)号:WO2014132244A9

    公开(公告)日:2014-11-27

    申请号:PCT/IB2014059351

    申请日:2014-02-28

    CPC classification number: C12Q1/6883 C12Q2600/156 G06F19/22

    Abstract: Methods are provided for diagnosing pregnancy-associated disorders, determining allelic ratios, determining maternal or fetal contributions to circulating transcripts, and/or identifying maternal or fetal markers using a sample from a pregnant female subject. Also provided is use of a gene for diagnosing a pregnancy-associated disorder in a pregnant female subject.

    Abstract translation: 提供了用于诊断妊娠相关疾病,确定等位基因比例,确定循环转录物的母体或胎儿贡献,和/或使用来自怀孕女性受试者的样品鉴定母体或胎儿标记的方法。 还提供了用于诊断怀孕女性受试者的怀孕相关疾病的基因的使用。

    MUTATIONAL ANALYSIS OF PLASMA DNA FOR CANCER DETECTION
    2.
    发明申请
    MUTATIONAL ANALYSIS OF PLASMA DNA FOR CANCER DETECTION 审中-公开
    用于癌症检测的血浆DNA的突变分析

    公开(公告)号:WO2013190441A3

    公开(公告)日:2014-02-27

    申请号:PCT/IB2013054898

    申请日:2013-06-14

    Abstract: A frequency of somatic mutations in a biological sample (e.g., plasma or serum) of a subject undergoing screening or monitoring for cancer, can be compared with that in the constitutional DNA of the same subject. A parameter can derived from these frequencies and used to determine a classification of a level of cancer. False positives can be filtered out by requiring any variant locus to have at least a specified number of variant sequence reads (tags), thereby providing a more accurate parameter. The relative frequencies for different variant loci can be analyzed to determine a level of heterogeneity of tumors in a patient.

    Abstract translation: 可以将经历筛选或监测癌症的受试者的生物样品(例如血浆或血清)中的体细胞突变的频率与同一受试者的结构DNA中的体细胞突变的频率进行比较。 一个参数可以从这些频率导出,用于确定癌症水平的分类。 可以通过要求任何变体轨迹至少具有指定数量的变体序列读取(标签)来过滤掉假阳性,从而提供更准确的参数。 可以分析不同变体基因座的相对频率,以确定患者肿瘤异质性水平。

    SIZE-BASED ANALYSIS OF FETAL DNA FRACTION IN MATERNAL PLASMA
    3.
    发明申请
    SIZE-BASED ANALYSIS OF FETAL DNA FRACTION IN MATERNAL PLASMA 审中-公开
    母婴血浆中胎儿DNA分数的基于尺度的分析

    公开(公告)号:WO2013132305A8

    公开(公告)日:2013-11-21

    申请号:PCT/IB2013000312

    申请日:2013-03-08

    Abstract: A fractional concentration of clinically-relevant DNA in a mixture of DNA from a biological sample is determined based on amounts of DNA fragments at multiple sizes. For example, the fractional concentration of fetal DNA in maternal plasma or tumor DNA in a patient's plasma can be determined. The size of DNA fragments in a sample is shown to be correlated with a proportion of fetal DNA and a proportion of tumor DNA, respectively. Calibration data points (e.g., as a calibration function) indicate a correspondence between values of a size parameter and the fractional concentration of the clinically-relevant DNA. For a given sample, a first value of a size parameter can be determined from the sizes of DNA fragments in a sample. A comparison of the first value to the calibration data points can provide the estimate of the fractional concentration of the clinically-relevant DNA.

    Abstract translation: 基于多种大小的DNA片段的量确定来自生物样品的DNA的混合物中的临床相关DNA的分数浓度。 例如,可以确定患者血浆中母体血浆或肿瘤DNA中胎儿DNA的分数浓度。 显示样品中DNA片段的大小分别与胎儿DNA的比例和肿瘤DNA的比例相关。 校准数据点(例如,作为校准函数)指示尺寸参数的值与临床相关DNA的分数浓度之间的对应关系。 对于给定的样品,尺寸参数的第一个值可以根据样品中DNA片段的大小确定。 第一个值与校准数据点的比较可以提供临床相关DNA分数浓度的估计值。

Patent Agency Ranking